As more companies embark on growth strategies leveraging IP development, understanding the types of IP – how they are created, owned, managed or accessing the rights, is crucial for the enterprise. Whether the IP is a patent, copyright, trademark or trade secret, it protects a company’s investment in branding or research and development (R&D). Such protection offers the enterprise sustained competitiveness in the global marketplace.
With IPI’s role in connecting enterprises to innovation, it is relevant to bring awareness about the importance of IP rights and management, be it for self-developed IP or IP through the adoption of open innovation that can take the form of licensing or R&D collaboration.
Complementing the mission of IE Singapore in assisting companies in their international expansion, IPI’s Senior Director, Dr Sze Tiam Lin was invited to conduct a sharing session with the various Divisions in IE Singapore on how companies could review or manage its IP assets, as well as pursue an IP strategy that aligns to business goals for growth and internationalisation.
The sharing also highlighted issues relating to IP models such as ownership and right-of-use in collaboration; and issues relating to IP transactions, with case studies of Singapore-based enterprises to illustrate how they had overcome their IP challenges with effective strategies to generate new growth opportunities.
The session received favourable feedback from the attendees. Lucas Li, Manager of the Technology Division said, “The talk has helped to deepen my knowledge of IP, especially in the area of challenges relating to IP and the strategies to overcome them which would be useful for enterprises to be aware of before any issues arise.
The sixth Innovation and Enterprise Office (IEO) Forum hosted by Ngee Ann Polytechnic on 27 September brought together over 70 representatives from...Read More
The printed circuit board (PCB) has a place in almost all electronic products we see today. Whether it is found in a medical device or a home...Read More
The regulatory framework for commercialisation of medical and health products continue to evolve with innovation developments and increasing health...Read More
Enterprise Singapore (ESG) and IPI were invited to share about corporate innovation opportunities in Singapore with members of Singapore...Read More